Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

REGN Regeneron Pharmaceuticals

Closed Independence Day 07-02 16:00:00 EDT

654.27

+29.55

+4.73%

盘后654.27

+0.000.00%

19:29 EDT

High654.94	Low625.70	Vol1.07M
Open630.52	D1 Closing624.72	Amplitude4.68%
Mkt Cap69.17B	Tradable Cap67.59B	Total Shares105.72M
T/O693.48M	T/O Rate1.04%	Tradable Shares103.30M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"Regeneron Pharmaceuticals","latestPrice":654.27,"timestamp":1783022400000,"preClose":624.72,"halted":0,"volume":1071604,"hourTrading":{"tag":"盘后","latestPrice":654.27,"preClose":654.27,"latestTime":"19:29 EDT","volume":44374,"amount":29032209.809,"timestamp":1783034982098,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.04730119093353815,"floatShares":103302739,"shares":105719806,"eps":41.06084,"marketStatus":"Closed Independence Day","change":29.55,"latestTime":"07-02 16:00:00 EDT","open":630.52,"high":654.935,"low":625.7,"amount":693476633.7956,"amplitude":0.046797,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":41.06084,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":624.72,"dividendRate":0.005563,"preHourTrading":{"tag":"盘前","latestPrice":624.72,"preClose":624.72,"latestTime":"08:34 EDT","volume":190,"amount":118654.16399999999,"timestamp":1782995689194,"change":0,"changeRate":0,"amplitude":0.02241},"postHourTrading":{"tag":"盘后","latestPrice":654.27,"preClose":654.27,"latestTime":"19:29 EDT","volume":44374,"amount":29032209.809,"timestamp":1783034982098,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1555909644358104,"impliedVol":0.334,"impliedVolPercentile":0.3506},"requestUrl":"/m/hq/s/REGN/tweets","defaultTab":"tweets","newsList":[{"id":"2648633246","title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2648633246","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648633246?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:44","pubTimestamp":1783025040,"startTime":"0","endTime":"0","summary":"DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  advanced 4.73% to $654.27 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  remaining mostly unchanged at 7,483.24 and the Dow Jones Industrial Average  rising 1.14% to 52,900.07.This was the stock's second consecutive day of gains.Regeneron Pharmaceuticals Inc. closed 20.32% below its 52-week high of $821.11, which the company achieved on January 9th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc.  rose 3.55% to $374.15, Moderna Inc.  rose 10.01% to $79.76, and Gilead Sciences Inc.  rose 4.21% to $131.27.Trading volume  remained 38,681 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 2, 20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159482347","title":"Movement Alert｜Regeneron Pharmaceuticals Rises 3.1% in Regular Trading, Selected for FDA Production Pilot Plus Priority Review for Novel Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1159482347","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159482347?lang=en_us&edition=fundamental","pubTime":"2026-07-02 22:53","pubTimestamp":1783004021,"startTime":"0","endTime":"0","summary":"On July 2, Regeneron Pharmaceuticals rose 3.1% in regular trading, trading at $644.35/share, with turnover of approximately $90.06 million. The stock was boosted by multiple positive catalysts on the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648551780","title":"Analysts Conflicted on These Healthcare Names: Alumis Inc. (ALMS), Glaukos (GKOS) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648551780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648551780?lang=en_us&edition=fundamental","pubTime":"2026-07-01 18:50","pubTimestamp":1782903027,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alumis Inc. (ALMS), Glaukos (GKOS) and Regeneron (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alumis-inc-alms-glaukos-gkos-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alumis-inc-alms-glaukos-gkos-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","LU0889565916.HKD","LU0114720955.EUR","LU0882574055.USD","BK4007","REGN","HCSG","LU2023250504.SGD","BK4139","ALMS","LU2362541513.USD","LU0029874061.USD","LU2106854487.HKD","LU0823434583.USD","LU2362540622.SGD","LU2237438978.USD","LU0109394709.USD","LU2065731478.USD","BK4581","LU0320765992.SGD","BK4548","LU2468319806.SGD","XBI","LU0823416689.USD","XLV","LU2089984988.USD","LABU","GKOS","BK4082","LU1917777945.USD","LU1878469433.USD","IE0009354923.USD","LU2362541273.HKD","LU0128526141.USD","BK4137","LU0053666078.USD","BK4585","LU0058720904.USD","LU1974910355.USD","LU0823434740.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648356269","title":"Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2648356269","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648356269?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:45","pubTimestamp":1782852300,"startTime":"0","endTime":"0","summary":"DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  slipped 1.31% to $623.54 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.79% to 7,499.36 and the Dow Jones Industrial Average  rising 0.26% to 52,319.20.This was the stock's second consecutive day of losses.Regeneron Pharmaceuticals Inc. closed 24.06% below its 52-week high of $821.11, which the company achieved on January 9th.The stock underperformed when compared to some of its competitors Tuesday, as Amgen Inc.  rose 0.44% to $362.12, Moderna Inc.  rose 0.47% to $70.03, and Gilead Sciences Inc.  rose 0.01% to $126.34.Trading volume  remained 243,985 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 30, 2026.This content was creat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647302883","title":"US FDA - Amneal, Cellares, Eli Lilly, Fujifilm, Kriya, Kyowa Kirin, Regeneron Join FDA Precheck Pilot","url":"https://stock-news.laohu8.com/highlight/detail?id=2647302883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647302883?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:26","pubTimestamp":1782764768,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43113I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BKPKM429.USD","IE00BJJMRY28.SGD","LU0689472784.USD","LU0820561909.HKD","LU2237438978.USD","LU2237443465.HKD","SG9999014898.SGD","LU2023250330.USD","LU2456880835.USD","LU1093756325.SGD","LU0203201768.USD","LU0320765992.SGD","SGXZ81514606.USD","LU2168564495.EUR","LU2237443978.SGD","IE0004445239.USD","LU2471134879.HKD","LU2168563687.JPY","BK4585","LU0158827948.USD","KYKOF","LU1323610961.USD","LU1093756168.USD","BK4007","LU0820562030.AUD","LU1983299246.USD","LU1232071149.USD","LU1267930730.SGD","LU2756315318.SGD","LU0787776722.HKD","BK4581","IE00B1BXHZ80.USD","SGXZ99366536.SGD","LU2471134952.CNY","IE00BJLML261.HKD","LU0210536198.USD","LU2491050154.USD","LU2471134523.USD","LU0417517546.SGD","LU0122379950.USD","LU1868837136.USD","IE00B1XK9C88.USD","LU0256863902.USD","LU0097036916.USD","LU0289739699.SGD","SG9999013999.USD","LU2168564149.EUR","LU1551013342.USD","LU1064131342.USD","LU2211815571.USD","BK4534","LU0466842654.USD","IE0002141913.USD","AMRX","LU0353189680.USD","BK4516","LU0708995401.HKD","IE00B4R5TH58.HKD","LU2756315664.SGD","IE00BK4W5M84.HKD","LU0964807845.USD","LU0106261372.USD","BK4588","LU0006306889.USD","LU1629891620.HKD","LU2111349929.HKD","LU2491050071.SGD","LU0353189763.USD","LLII","SG9999015978.USD","LU2324357040.USD","BK4139","LU2552382132.HKD","LU0471298777.SGD","LU0109391861.USD","LU2602419157.SGD","LU2746668461.USD","ELIS","LU0683600562.USD","LU0133085943.USD","LU1804176565.USD","LU2237443549.SGD","LLYX","LU0234572021.USD","LLY","LU2213496289.HKD","REGN","SGXZ57979304.SGD","LU1127390331.HKD","LU1551013425.SGD","LU0786609619.USD","IE00BFTCPJ56.SGD","IE00B7KXQ091.USD","LU0432979614.USD","IE0001KFT4U8.USD","LU0320765059.SGD","LU1366192091.USD","LU2264538146.SGD","LU0882574139.USD","LU2089984988.USD","LU1868837300.USD","LU0943347566.SGD","LU1989771016.USD","IE0005OL40V9.USD","LU0823434583.USD","LU2168564065.EUR","LU1291159041.SGD","LU2750360641.GBP","LU1023059063.AUD","LU0354030438.USD","LU2360106947.USD","BK4170","IE00BJT1NW94.SGD","LU0672654240.SGD","SG9999018857.SGD","LU1720051108.HKD","LU0471298694.HKD","LU0823416689.USD","LU1720051017.SGD","LU1868836757.USD","LU0158827781.USD","LU0094547139.USD","LU0203202063.USD","LU1974910355.USD","SGXZ31699556.SGD","SG9999014914.USD","IE00B775H168.HKD","LU1868836914.USD","LU2361044949.HKD","LU2552382215.SGD","LU1145028129.USD","IE00B4JS1V06.HKD","LU2108987350.USD","SG9999014906.USD","LU0820561818.USD","LU2362541513.USD","LU1057294990.SGD","LU0114720955.EUR","LU2271345857.HKD","LU0456855351.SGD","LU2112291526.USD","IE00B2B36J28.USD","LU2237443622.USD","LU0823434740.USD","LU2750360997.AUD","IE00BK4W5L77.USD","LU0323591593.USD","LU2462157665.USD","LU2023250504.SGD","LU0316494557.USD","ELIL","LLYZ","LU0225283273.USD","LU1069344957.HKD","LU1548497426.USD","IE00BFSS7M15.SGD","BK4533","LU0640476718.USD","LU2023251221.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU0256863811.USD","LU2362540622.SGD","SG9999015945.SGD","SG9999017495.SGD","LU0266013472.USD","IE00BJJMRX11.SGD","LU2471134796.USD","BK4599","LU0053666078.USD","LU2237443895.HKD","IE0009355771.USD","LU0096364046.USD","IE00BFSS8Q28.SGD","LU2746668974.SGD","LU0198837287.USD","LU2089284900.SGD","LU2106854487.HKD","LU0354030511.USD","LU2236285917.USD","LU0238689110.USD","LU2028103732.USD","LU2357305700.SGD","FUJIF","LU2896262040.SGD","SGXZ51526630.SGD","SG9999015986.USD","LU2237443382.USD","SG9999001176.SGD","LU1917777945.USD","GB00BDT5M118.USD","IE00BWXC8680.SGD","LU2063271972.USD","SG9999014880.SGD","LU2461242641.AUD","LU2361044865.SGD","LU0109394709.USD","LU0079474960.USD","LU2417539215.USD","SG9999018865.SGD","LU0882574055.USD","LU2491049909.HKD","LU2265009873.SGD","LU2362541273.HKD","LU1712237335.SGD","LU1280957306.USD","IE00BN29S564.USD","LU2468319806.SGD","LU0061475181.USD","LU1061106388.HKD","LU1814569148.SGD","LU0385154629.USD","LU1623119135.USD","LU2168564222.USD","LU1988902786.USD","LU0889565916.HKD","LU2087625088.SGD","LU2552382058.USD","LU2089283258.USD","LU1035775433.USD","LU0058720904.USD","LU2361045086.USD","IE0004445015.USD","IE00BKDWB100.SGD","SG9999015952.SGD","LU1868836591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647304917","title":"Market Chatter: Eli Lilly, Regeneron Among First Companies in FDA PreCheck Pilot Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2647304917","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647304917?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:00","pubTimestamp":1782763235,"startTime":"0","endTime":"0","summary":"Eli Lilly  and Regeneron Pharmaceuticals  are among the first seven companies selected by the U.S. Food and Drug Administration for a pilot program aimed at accelerating reviews of new domestic manufacturing facilities, CNBC reported Monday, citing FDA spokesperson Benjamin Nichols.The other participants in the FDA's PreCheck pilot program are Amneal Pharmaceuticals , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin, the report said.The program allows regulators to begin reviewing new manufacturing facilities while they are still under construction, which the agency estimates could save companies up to 14 months, according to the report.Eli Lilly, Regeneron and FDA did not immediately respond to requests for comment from MT Newswires.Price: 1228.24, Change: +20.12, Percent Change: +1.67","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0943347566.SGD","IE00BJLML261.HKD","LU1868837136.USD","LU2471134796.USD","LU0114720955.EUR","LU0708995401.HKD","LU1548497426.USD","LU2750360641.GBP","LU0787776722.HKD","LU0820562030.AUD","LU1291159041.SGD","LU0882574055.USD","LU2471134523.USD","SG9999014906.USD","IE0004445015.USD","LU2023250504.SGD","LU0823434583.USD","LU1093756325.SGD","LU2471134952.CNY","SG9999014914.USD","LU0097036916.USD","BK4581","LU1035775433.USD","LU1712237335.SGD","LU0353189763.USD","LU1267930730.SGD","LU2361045086.USD","IE00BKDWB100.SGD","LU2746668974.SGD","LU0466842654.USD","SGXZ99366536.SGD","LU0353189680.USD","LU2168563687.JPY","IE0002141913.USD","LU0210536198.USD","IE00B2B36J28.USD","LU0672654240.SGD","LU0203202063.USD","LU2108987350.USD","LU2089283258.USD","SG9999015978.USD","IE00BWXC8680.SGD","IE00BJJMRZ35.SGD","LU1629891620.HKD","LU0964807845.USD","SG9999001176.SGD","LU0058720904.USD","LU2750360997.AUD","LLII","LU0889565916.HKD","LU1983299246.USD","LU2360106947.USD","LU0079474960.USD","LU2213496289.HKD","LU1145028129.USD","LU2756315664.SGD","LU0238689110.USD","LU2417539215.USD","SGXZ31699556.SGD","LU1988902786.USD","LU2552382215.SGD","REGN","LU0354030438.USD","IE0001KFT4U8.USD","LU0683600562.USD","LLYX","LU1232071149.USD","LU2168564222.USD","LU2106854487.HKD","LU2362540622.SGD","LU0225283273.USD","LU0882574139.USD","LLYZ","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU1551013425.SGD","LU2468319806.SGD","LU2211815571.USD","BK4533","SG9999017495.SGD","LU2461242641.AUD","LU2602419157.SGD","IE00BJJMRY28.SGD","LU2237443895.HKD","LU1023059063.AUD","LU2491050154.USD","SG9999015945.SGD","LU1720051108.HKD","LU2362541273.HKD","LU2237443549.SGD","LLY","LU0158827948.USD","LU1551013342.USD","IE0009355771.USD","LU0471298777.SGD","LU1127390331.HKD","LU1280957306.USD","LU1868836914.USD","LU1974910355.USD","LU2111349929.HKD","LU0786609619.USD","IE0004445239.USD","LU2896262040.SGD","SGXZ81514606.USD","LU0289739699.SGD","LU0820561818.USD","LU0234572021.USD","SG9999018865.SGD","LU0256863811.USD","LU2168564065.EUR","IE00BK4W5M84.HKD","LU0266013472.USD","BK4007","BK4534","LU2265009873.SGD","LU2271345857.HKD","LU1069344957.HKD","BK4139","BK4516","LU2362541513.USD","LU0109391861.USD","LU2456880835.USD","IE00BJJMRX11.SGD","LU2112291526.USD","SG9999013999.USD","LU2237438978.USD","SGXZ57979304.SGD","LU0109394709.USD","SG9999018857.SGD","IE00B775H168.HKD","IE00BN29S564.USD","LU0385154629.USD","LU1720051017.SGD","LU0417517546.SGD","LU1061106388.HKD","LU1366192091.USD","SGXZ51526630.SGD","LU0158827781.USD","SG9999014898.SGD","LU2089984988.USD","LU2264538146.SGD","LU1868837300.USD","LU0203201768.USD","LU1804176565.USD","LU1064131342.USD","BK4599","LU1623119135.USD","LU1917777945.USD","SG9999001176.USD","ELIS","LU2361044949.HKD","IE00BK4W5L77.USD","LU0106261372.USD","LU1868836591.USD","LU2552382132.HKD","LU0053666078.USD","LU2023250330.USD","IE00BFSS7M15.SGD","LU0823434740.USD","BK4588","LU0096364046.USD","LU2023251221.USD","SG9999015986.USD","LU0820561909.HKD","LU2361044865.SGD","LU0256863902.USD","LU2746668461.USD","LU0432979614.USD","ELIL","LU2471134879.HKD","LU1868836757.USD","IE0005OL40V9.USD","LU2491049909.HKD","LU0471298694.HKD","LU2236285917.USD","LU2357305700.SGD","LU2237443382.USD","LU2237443978.SGD","LU0689472784.USD","LU2552382058.USD","SG9999015952.SGD","IE00B1XK9C88.USD","IE00BJT1NW94.SGD","LU1989771016.USD","LU2168564495.EUR","LU2028103732.USD","IE00B4R5TH58.HKD","LU2237443622.USD","IE00B4JS1V06.HKD","LU0323591593.USD","LU0122379950.USD","LU0354030511.USD","IE00BFSS8Q28.SGD","LU0006306889.USD","LU0640476718.USD","LU0320765059.SGD","LU2168564149.EUR","LU2491050071.SGD","LU0133085943.USD","LU0823416689.USD","IE00B1BXHZ80.USD","LU2089284900.SGD","LU2756315318.SGD","LU0061475181.USD","GB00BDT5M118.USD","LU0094547139.USD","SG9999014880.SGD","LU0198837287.USD","LU1814569148.SGD","LU1057294990.SGD","IE00B7KXQ091.USD","IE00BKPKM429.USD","LU0316494557.USD","LU2063271972.USD","BK4585","LU1093756168.USD","LU1323610961.USD","LU2087625088.SGD","LU2237443465.HKD","LU2462157665.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647301276","title":"Lilly, Regeneron Selected for US Program to Review New Manufacturing Plants Faster","url":"https://stock-news.laohu8.com/highlight/detail?id=2647301276","media":"Reuters","labels":["policyRegulatory","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647301276?lang=en_us&edition=fundamental","pubTime":"2026-06-30 03:11","pubTimestamp":1782760309,"startTime":"0","endTime":"0","summary":"UPDATE 3-Lilly, Regeneron selected for US program to review new manufacturing plants fasterUpdates to change sourcingJune 29 (Reuters)-The U.S. Food and Drug Administration on Monday selected Eli Lill","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nL4N4311HH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1712237335.SGD","BK4581","LU1366192091.USD","LU0006306889.USD","LLYX","LU0708995401.HKD","LU0238689110.USD","SG9999014914.USD","LU2271345857.HKD","LU0053666078.USD","LLII","LU1917777945.USD","LU0823434740.USD","LU1023059063.AUD","LU2237443978.SGD","IE0004445239.USD","LU2756315318.SGD","LU0122379950.USD","LU0256863811.USD","LU0353189763.USD","LU0158827948.USD","LU2756315664.SGD","LU0820561909.HKD","LU2111349929.HKD","IE00BK4W5M84.HKD","LU2602419157.SGD","REGN","ELIL","IE00B4R5TH58.HKD","LU1974910355.USD","LU2089283258.USD","LU1814569148.SGD","SGXZ51526630.SGD","AMRX","LU2168563687.JPY","ELIS","LLYZ","LU1069344957.HKD","LU1548497426.USD","LU1551013342.USD","LU2236285917.USD","LU2168564065.EUR","IE0001KFT4U8.USD","LU0320765059.SGD","SGXZ57979304.SGD","LU0109394709.USD","IE0009355771.USD","LLY","LU2023250504.SGD","LU2211815571.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647671301","title":"Eli Lilly, Regeneron among first selections for FDA PreCheck program, CNBC says","url":"https://stock-news.laohu8.com/highlight/detail?id=2647671301","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647671301?lang=en_us&edition=fundamental","pubTime":"2026-06-30 03:00","pubTimestamp":1782759612,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY), Regeneron (REGN), Amneal (AMRX), Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-regeneron-among-first-selections-for-fda-precheck-program-cnbc-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-regeneron-among-first-selections-for-fda-precheck-program-cnbc-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1623119135.USD","LU2746668974.SGD","IE0005OL40V9.USD","LU0354030511.USD","LU2265009873.SGD","LU0787776722.HKD","SGXZ31699556.SGD","LU1127390331.HKD","SG9999015978.USD","LU0823434740.USD","LU1974910355.USD","LU2468319806.SGD","LU2461242641.AUD","LU0053666078.USD","LU2471134796.USD","LU1868836591.USD","SG9999015945.SGD","LU0353189680.USD","LU1267930730.SGD","LU2491050071.SGD","LU2750360641.GBP","SG9999001176.USD","SG9999017495.SGD","LU0882574139.USD","LU0122379950.USD","LU2552382132.HKD","LLII","BK4581","LU2237443622.USD","BK4139","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU0417517546.SGD","IE00B1XK9C88.USD","LU1988902786.USD","LU1720051108.HKD","LU0889565916.HKD","LU2089284900.SGD","LU2552382215.SGD","LU0385154629.USD","LU2746668461.USD","LU2750360997.AUD","LU2552382058.USD","IE00BK4W5L77.USD","LU0823434583.USD","LU1145028129.USD","LU1712237335.SGD","LU1035775433.USD","LU1061106388.HKD","LU0114720955.EUR","LU1232071149.USD","LU1323610961.USD","LU0708995401.HKD","BK4533","LU0210536198.USD","SG9999018865.SGD","LU0432979614.USD","LU0353189763.USD","LU2471134879.HKD","LU1868837136.USD","LU0256863902.USD","LU0158827781.USD","LU1868837300.USD","LU1983299246.USD","SG9999014880.SGD","IE00BFTCPJ56.SGD","SG9999014906.USD","ELIL","LU0882574055.USD","LU2089283258.USD","LU0079474960.USD","LLYX","LU1093756325.SGD","LU0689472784.USD","LU0323591593.USD","LU2087625088.SGD","IE00BJJMRY28.SGD","LU1804176565.USD","LU0456855351.SGD","LU2063271972.USD","LU2213496289.HKD","LU1057294990.SGD","LU2756315664.SGD","LU2028103732.USD","IE00BKDWB100.SGD","LU2023251221.USD","LU1551013342.USD","LU0466842654.USD","LU1023059063.AUD","LU0061475181.USD","LU1814569148.SGD","LU0320765059.SGD","LU2168563687.JPY","LU1064131342.USD","SG9999014914.USD","LU1868836757.USD","LU0964807845.USD","LU0256863811.USD","BK4599","IE0004445015.USD","IE00B775H168.HKD","LU0683600562.USD","LU0106261372.USD","LU2168564149.EUR","LU2211815571.USD","LU2462157665.USD","SG9999001176.SGD","LU1280957306.USD","LU0203201768.USD","LU2362540622.SGD","LU2237443465.HKD","LU2023250504.SGD","LU2324357040.USD","LU0820561818.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0823416689.USD","LU0786609619.USD","GB00BDT5M118.USD","LLYZ","LU1093756168.USD","LU0471298777.SGD","LU0109391861.USD","LU0238689110.USD","SG9999013999.USD","BK4585","LU1548497426.USD","SGXZ57979304.SGD","LU0058720904.USD","BK4588","LU0094547139.USD","LU2456880835.USD","LU2896262040.SGD","SGXZ81514606.USD","IE00BWXC8680.SGD","IE00BJT1NW94.SGD","LU0234572021.USD","LU1069344957.HKD","LU1291159041.SGD","LU0203202063.USD","LU1551013425.SGD","LU2168564222.USD","LU2361044865.SGD","LU2491049909.HKD","SG9999018857.SGD","LU0289739699.SGD","IE00BJLML261.HKD","LU2089984988.USD","LU0225283273.USD","LU2237443549.SGD","LU0006306889.USD","SGXZ51526630.SGD","LU1868836914.USD","LU2108987350.USD","LU2756315318.SGD","LU1989771016.USD","LU0198837287.USD","LLY","LU0096364046.USD","BK4534","IE00BN29S564.USD","LU2417539215.USD","LU1366192091.USD","IE00BFSS7M15.SGD","LU1917777945.USD","LU0471298694.HKD","LU2491050154.USD","IE00BFSS8Q28.SGD","LU2023250330.USD","IE00B2B36J28.USD","LU0316494557.USD","LU0943347566.SGD","LU0672654240.SGD","SG9999014898.SGD","LU2111349929.HKD","LU2237443895.HKD","IE0004445239.USD","LU0820562030.AUD","LU0266013472.USD","LU2106854487.HKD","LU2362541513.USD","IE00BJJMRX11.SGD","LU2168564495.EUR","SG9999015952.SGD","LU2237438978.USD","LU1629891620.HKD","IE00BKPKM429.USD","LU2471134523.USD","IE0009355771.USD","BK4516","LU2236285917.USD","LU0133085943.USD","ELIS","REGN","BK4007","LU0354030438.USD","LU0820561909.HKD","LU0158827948.USD","LU2271345857.HKD","LU2357305700.SGD","IE00B4JS1V06.HKD","LU2360106947.USD","LU2361045086.USD","LU2471134952.CNY","SG9999015986.USD","LU2361044949.HKD","IE00B1BXHZ80.USD","LU2168564065.EUR","IE00BK4W5M84.HKD","IE0002141913.USD","LU2602419157.SGD","LU2264538146.SGD","LU2112291526.USD","LU2362541273.HKD","AMRX","SGXZ99366536.SGD","LU0097036916.USD","LU2237443382.USD","LU2237443978.SGD","LU1720051017.SGD","LU0109394709.USD","LU0640476718.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647533301","title":"Eli Lilly, Regeneron Among First Companies Selected for FDA Initiative to Speed Review of New Manufacturing Facilities - CNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2647533301","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647533301?lang=en_us&edition=fundamental","pubTime":"2026-06-30 02:52","pubTimestamp":1782759146,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43110W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2362541513.USD","LU0320765059.SGD","LU1989771016.USD","LU2746668461.USD","LU0158827948.USD","LU0323591593.USD","LU1814569148.SGD","IE00BKDWB100.SGD","LU0114720955.EUR","BK4139","IE00BJLML261.HKD","LU0097036916.USD","LU0823434583.USD","LU1023059063.AUD","LU0006306889.USD","LU1868837300.USD","BK4516","LU2106854487.HKD","LU2237443978.SGD","SG9999014906.USD","IE00BJJMRZ35.SGD","IE00BK4W5M84.HKD","LU0882574055.USD","SG9999014880.SGD","LU2237443382.USD","LU1069344957.HKD","LU2361045086.USD","LU0353189680.USD","SG9999015978.USD","LU0256863811.USD","IE00B1XK9C88.USD","LU1868836914.USD","LU1917777945.USD","LU0158827781.USD","LU0210536198.USD","LU0289739699.SGD","LU0787776722.HKD","LU2111349929.HKD","LU2168564149.EUR","LU2063271972.USD","LU2237443895.HKD","LU2089283258.USD","LU1035775433.USD","LU2237438978.USD","LU2028103732.USD","LU2750360997.AUD","SGXZ51526630.SGD","LU1868836591.USD","LU2264538146.SGD","SG9999013999.USD","LU0225283273.USD","LU2357305700.SGD","LU1291159041.SGD","LU1323610961.USD","IE0005OL40V9.USD","LU2237443622.USD","LU1061106388.HKD","LU0417517546.SGD","LU0689472784.USD","LU1868836757.USD","IE00BJJMRX11.SGD","LU2361044865.SGD","SG9999015945.SGD","LU0889565916.HKD","LU0943347566.SGD","BK4533","LU2602419157.SGD","LU0820561818.USD","LU2756315318.SGD","LU2756315664.SGD","LU2471134879.HKD","SGXZ81514606.USD","LU2168564495.EUR","LU2360106947.USD","LU2896262040.SGD","IE0009355771.USD","LU2023250504.SGD","LU2468319806.SGD","IE00B7KXQ091.USD","LU1720051017.SGD","LU0320765992.SGD","LU1623119135.USD","LU2236285917.USD","LU2265009873.SGD","SG9999001176.SGD","SG9999015952.SGD","LU2023250330.USD","LU0456855351.SGD","LU0238689110.USD","LU2089284900.SGD","SG9999018857.SGD","LU0061475181.USD","LU2552382058.USD","SG9999014898.SGD","IE00BK4W5L77.USD","LU2750360641.GBP","LU2552382215.SGD","LU0786609619.USD","LU1551013425.SGD","LU1629891620.HKD","LU2087625088.SGD","LU0106261372.USD","LU2324357040.USD","IE00BWXC8680.SGD","IE00BN29S564.USD","LU2746668974.SGD","IE00BJT1NW94.SGD","LU2237443465.HKD","LU0432979614.USD","SG9999001176.USD","LU2471134523.USD","IE00B775H168.HKD","LU1988902786.USD","REGN","LU1804176565.USD","BK4585","LU2456880835.USD","IE00B2B36J28.USD","IE00BJJMRY28.SGD","LU2089984988.USD","LU0316494557.USD","IE00B4R5TH58.HKD","LU1267930730.SGD","LU0198837287.USD","LU2362540622.SGD","LLYZ","LLII","LU1093756325.SGD","LU2168564222.USD","IE00BFSS8Q28.SGD","LU0133085943.USD","LLYX","LU0203202063.USD","LU2471134952.CNY","LU1145028129.USD","BK4599","LU2112291526.USD","SG9999017495.SGD","BK4007","IE0001KFT4U8.USD","LU0094547139.USD","LU0203201768.USD","LU0471298694.HKD","LU1983299246.USD","SGXZ99366536.SGD","LU2271345857.HKD","LU0672654240.SGD","SGXZ31699556.SGD","LU2211815571.USD","LU2108987350.USD","LU0708995401.HKD","LU1366192091.USD","SG9999015986.USD","LU2462157665.USD","IE0002141913.USD","LU0096364046.USD","LU0964807845.USD","LU0053666078.USD","LU0820562030.AUD","LU2362541273.HKD","LU1548497426.USD","LU2491049909.HKD","ELIL","LU0823416689.USD","LU0683600562.USD","SG9999014914.USD","IE00B1BXHZ80.USD","LU0466842654.USD","LU2361044949.HKD","IE0004445239.USD","LU0471298777.SGD","LU1232071149.USD","LU2023251221.USD","LU0353189763.USD","LU2168564065.EUR","SGXZ57979304.SGD","LU0354030511.USD","LU0882574139.USD","LU0266013472.USD","LU0820561909.HKD","LU0385154629.USD","LU1057294990.SGD","LU1712237335.SGD","LU2491050154.USD","IE00BFTCPJ56.SGD","SG9999018865.SGD","BK4581","LU1551013342.USD","LU1064131342.USD","LU2491050071.SGD","LU1280957306.USD","IE00B4JS1V06.HKD","LU0122379950.USD","LU0823434740.USD","IE00BFSS7M15.SGD","LU0256863902.USD","LU2471134796.USD","LU2417539215.USD","LU2552382132.HKD","LU2237443549.SGD","LU2461242641.AUD","LLY","LU0109394709.USD","LU0354030438.USD","LU1093756168.USD","BK4534","LU1127390331.HKD","LU0079474960.USD","LU1720051108.HKD","LU0058720904.USD","LU0640476718.USD","LU1868837136.USD","ELIS","GB00BDT5M118.USD","LU1974910355.USD","LU0234572021.USD","BK4588","LU2213496289.HKD","IE0004445015.USD","IE00BKPKM429.USD","LU2168563687.JPY","LU0109391861.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646736234","title":"Healthcare Stocks Have Become a Haven for Investors Ditching Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2646736234","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646736234?lang=en_us&edition=fundamental","pubTime":"2026-06-27 10:30","pubTimestamp":1782527400,"startTime":"0","endTime":"0","summary":"AbbVie, Lilly and J&J’s shares all closed at all-time highs.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000SO60NU8.SGD","LU1868836757.USD","LU2471134952.CNY","IE00BJJMRY28.SGD","LU1983299246.USD","LU2491050071.SGD","LU0354030511.USD","LU0353189763.USD","LU2089984988.USD","LU2462157665.USD","LU1839511570.USD","LU1430594728.SGD","LU0094547139.USD","LU0708994859.HKD","LU1093756168.USD","LU1244550221.USD","LU2111349929.HKD","LU2129689605.HKD","LU0256863811.USD","BK4504","IE00B42XCP33.USD","IE00BKVL7J92.USD","IE000WAW04H5.SGD","LU2168564495.EUR","SG9999017495.SGD","IE00BJJMRX11.SGD","IE000F7OJYX1.SGD","MRNY","LU2213496289.HKD","LU0965508806.USD","LU0985320562.USD","SG9999003800.SGD","IE0004445015.USD","LU1244550577.SGD","GB00BDT5M118.USD","LU1043141123.HKD","LU1934455194.USD","LU1037948541.HKD","LU0889565916.HKD","LU0964807845.USD","IE00BN29S564.USD","LU2133065610.SGD","IE00BLSP4239.USD","LU0345770308.USD","LU2746668461.USD","LU1003077747.HKD","LU0234572021.USD","LU2417539215.USD","LU0426412945.USD","LU0868494617.USD","JNJ","LU2236285917.USD","LU2750360997.AUD","LU1934455863.HKD","LU2403377893.USD","LU2361044949.HKD","IE00BBT3K403.USD","LU1043141396.HKD","LU2087625088.SGD","LU1261432733.SGD","IE00BKPKM429.USD","LU2023250330.USD","LU0170899867.USD","SG9999013999.USD","LU0124676726.USD","BK4532","ABBV","IE0005OL40V9.USD","LU0417517546.SGD","LU2750360641.GBP","LU0861579265.USD","LU1914381329.SGD","BK4533","LU0316494557.USD","LU1267930730.SGD","LU1061106388.HKD","SG9999015945.SGD","LU1585245621.USD","LU0965509283.SGD","LU0289961442.SGD","LU2087621335.USD","IE00BJLML261.HKD","LU0385154629.USD","BK4599","LU0353189680.USD","LU0820561818.USD","ABSI","LU0965509010.AUD","LU1868837300.USD","LU0672654240.SGD","SGXZ57979304.SGD","LU0640476718.USD","LU1232071149.USD","LU0882574055.USD","LU2592432038.USD","LU1066053197.SGD","LU1868837136.USD","LU0511384066.AUD","LU0859254822.USD","LU2505996681.GBP","LU1291159041.SGD","LU2237443465.HKD","BK4534","LU0471298694.HKD","LU2430703095.HKD","LU1267930813.SGD","LU2108987350.USD","LU1032955483.USD","LU2264538146.SGD","LU2505996509.AUD","LU0323591593.USD","LU0823434740.USD","LU1496350502.SGD","BK4581","SGXZ31699556.SGD","LU2168564149.EUR","LU0994945656.USD","LU1093756325.SGD","LU1804176565.USD","LU1323610961.USD","LU0289739699.SGD","LU0345769128.USD","LU1221951046.USD","LU2491050154.USD","IE00BDGV0183.EUR","IE00B1BXHZ80.USD","IE000BZT7R73.USD","IE00BLSP4452.SGD","LU0310800379.SGD","IE00B7SZLL34.SGD","LU0069063385.USD","LU1732800096.USD","LU0553294199.USD","LU0823434583.USD","LU1267930573.SGD","IE00B4JS1V06.HKD","LU0787776722.HKD","IE00BZ1G4Q59.USD","LU1280957306.USD","LU0203202063.USD","LU0225283273.USD","LU0472753341.HKD","IE00B7KXQ091.USD","LU0109394709.USD","LU2468319806.SGD","LU1674673691.USD","LU1623119135.USD","LU2112291526.USD","LU1244550494.USD","LU2271345857.HKD","LU1894683348.USD","SG9999002224.SGD","LU0098860793.USD","LU0354030438.USD","LU0345769631.USD","LU0432979614.USD","LLYZ","SG9999015986.USD","LU1069344957.HKD","LU0320765059.SGD","LU2471134879.HKD","LU2347655156.SGD","LU0234570918.USD","LU1974910355.USD","LU1894683264.USD","LU1228905540.USD","LU2896262040.SGD","IE00B775H168.HKD","SG9999001176.SGD","LU1506573853.SGD","LU1814569148.SGD","LU2756315318.SGD","LU2552382215.SGD","LU0689472784.USD","LU1548497426.USD","LU0210528500.USD","LU0820562030.AUD","LU0738911758.USD","LU1145028129.USD","LU1221951129.SGD","LU0057025933.USD","LU2237443978.SGD","LU1196500208.SGD","IE00BJJMRZ35.SGD","LU0158827948.USD","IE00BSNM7G36.USD","BK4139","LU0053666078.USD","LU1670628061.USD","LU0792757196.USD","LU2265009873.SGD","LU2089284900.SGD","BK4559","LU0545039389.USD","IE00B3PB1722.GBP","IE0001KFT4U8.USD","IE00B1XK9C88.USD","LU1718418525.SGD","LU1929549753.HKD","LU0266013472.USD","LU0058720904.USD","SG9999002232.USD","LU0203347892.USD","LU1934455277.USD","LU2237443382.USD","SG9999018857.SGD","LU2746668974.SGD","LU1162221912.USD","SG9999014906.USD","LU1037948897.HKD","IE00BVYPNW00.USD","LU0889566641.SGD","LU2461242641.AUD","SNY","LU0029864427.USD","LU0310799852.SGD","LU2129689514.USD","SGXZ81514606.USD","LU2168563687.JPY","LU1629891620.HKD","LU1670627923.USD","SGXZ99366536.SGD","BK4568","XBI","IE0000B7K699.USD","IE00BKDWB100.SGD","LU1496350171.SGD","LU0868494708.USD","LU0320765646.SGD","LU1868836591.USD","BK4550","IE00B19Z3581.USD","IE00BK4W5M84.HKD","LU1720051108.HKD","SG9999014880.SGD","LU1551013425.SGD","IE00BN8TJ469.HKD","LU1066051811.HKD","IE00BJT1NW94.SGD","BK4585","LU2602419157.SGD","LU0203201768.USD","SG9999015978.USD","LU2487616109.SGD","LLY","IE000MB6IJN5.SGD","IE00BFTCPJ56.SGD","LU1989771016.USD","LU2237438978.USD","LU0345770993.USD","SG9999015952.SGD","LU0210536198.USD","LU2552382058.USD","LU2357627491.SGD","LU0795875086.SGD","SG9999014898.SGD","LU1127390331.HKD","LU1989772840.SGD","IE00BFSS8Q28.SGD","LU2106854487.HKD","LU2237443895.HKD","LU1066051225.USD","LU2168564222.USD","LU2491049909.HKD","SG9999001440.SGD","LU1057294990.SGD","BK4516","LU0198837287.USD","IE000M9KFDE8.USD","IE00BWXC8680.SGD","LU0466842654.USD","LU0456855351.SGD","LU1121112475.USD","APGE","LU2129689431.USD","LU2471134796.USD","ELIL","LU1064131342.USD","IE00BFSS7M15.SGD","LU0211327993.USD","IE00B2B36J28.USD","LU0965509101.SGD","IE0002270589.USD","LU2756315664.SGD","LU0882574139.USD","LU0238689110.USD","LU2237443622.USD","LU2456880835.USD","BK4588","LU0661504455.SGD","LU0203345920.USD","LU2324357040.USD","LU1674673428.USD","LU0133085943.USD","IE0034235303.USD","LU0949170772.SGD","LU2361045086.USD","LU2471134523.USD","LU0122379950.USD","LLII","LU0942090050.USD","LLYX","LU2430703251.USD","LU2063271972.USD","LU2357305700.SGD","LU2237443549.SGD","LU0912757837.SGD","LU0708995401.HKD","SGXZ51526630.SGD","LU0683600562.USD","LU0211328371.USD","LU0006306889.USD","LU0823416689.USD","LU1059921491.USD","LU1551013342.USD","LU1023059063.AUD","LU0061475181.USD","SG9999014914.USD","LU1935042991.SGD","LU1032466523.USD","REGN","LU1720051017.SGD","LU2552382132.HKD","LU0128525929.USD","LU2430703178.SGD","LU0471298777.SGD","MRNX","BK4007","IE0004445239.USD","LU2168564065.EUR","IE00BVYPNV92.GBP","LU0256863902.USD","LU1035775433.USD","LU1074936037.SGD","MRNA","LU0943347566.SGD","SG9999001176.USD","LU0795875169.SGD","LU2211815571.USD","LU0158827781.USD","LU0320765992.SGD","LU0786609619.USD","LU1988902786.USD","LU0426417589.USD","LU1228905037.USD","LU0070217475.USD","BK4592","LU1366192091.USD","LU1917777945.USD","IE00B3T34201.USD","IE0002141913.USD","LU0545562505.USD","LU2089283258.USD","SG9999011175.SGD","LU2028103732.USD","LU0079474960.USD","LU0820561909.HKD","LU0096364046.USD","BK4566","LU0689626769.HKD","LU1778281490.HKD","IE00B4R5TH58.HKD","LU0114720955.EUR","LU2023250504.SGD","IE00BFXG1179.USD","IE00BK4W5L77.USD","LU2023251221.USD","LU0097036916.USD","IE0009355771.USD","SG9999018865.SGD","ELIS","LU0289739343.SGD","LU1732799900.SGD","LU2361044865.SGD","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","LU0106261372.USD","LU1868836914.USD","LU1066051498.USD","LU0109391861.USD","XLV","LU1989772923.USD","LU1712237335.SGD","LU1267930490.SGD","LU2360106947.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646801398","title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2646801398","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646801398?lang=en_us&edition=fundamental","pubTime":"2026-06-27 04:45","pubTimestamp":1782506700,"startTime":"0","endTime":"0","summary":"DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  rallied 2.06% to $632.90 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.05% to 7,354.02 and Dow Jones Industrial Average  falling 0.09% to 51,876.11.Regeneron Pharmaceuticals Inc. closed 22.92% short of its 52-week high of $821.11, which the company reached on January 9th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc.  rose 1.56% to $358.33, Moderna Inc.  rose 12.59% to $67.27, and Gilead Sciences Inc.  rose 3.26% to $127.88.Trading volume  eclipsed its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 26, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. Ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646367555","title":"How Investors May Respond To Regeneron Pharmaceuticals (REGN) Cemdisiran Priority Review for gMG Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2646367555","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646367555?lang=en_us&edition=fundamental","pubTime":"2026-06-27 03:16","pubTimestamp":1782501384,"startTime":"0","endTime":"0","summary":"Earlier this week, Regeneron Pharmaceuticals reported that both the FDA and EMA accepted regulatory applications for cemdisiran to treat anti‑AChR antibody‑positive generalized myasthenia gravis, with the FDA granting Priority Review and a target action date in November 2026.\nIf approved, cemdisiran could become the first siRNA therapy for gMG and the only option given subcutaneously just four times a year, potentially easing treatment burden for patients who often struggle with chronic...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/how-investors-may-respond-to-regeneron-pharmaceuticals-regn","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/how-investors-may-respond-to-regeneron-pharmaceuticals-regn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2468319806.SGD","LU0882574055.USD","BK4139","LU0889565916.HKD","LU2362541273.HKD","AGIX","ARTY","LU0114720955.EUR","LU2089984988.USD","REGN","AIPO","CHAT","LU0289739699.SGD","BK4588","LU2237438978.USD","BK4585","LU2106854487.HKD","LU0053666078.USD","LU0320765992.SGD","LU1917777945.USD","LU0823434583.USD","LU2362540622.SGD","LU0823416689.USD","LU2362541513.USD","LU0823434740.USD","LU1974910355.USD","LU0109394709.USD","LU0058720904.USD","BK4211","ISBC","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646856413","title":"Regeneron Updates Financial Calendar for Second-quarter Results Release and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2646856413","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646856413?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:05","pubTimestamp":1782417918,"startTime":"0","endTime":"0","summary":"Regeneron updates financial calendar for second-quarter results release and conference callRegeneron schedules release of Q2 2026 financial and operating results on July 30, 2026, before the US market","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL158mhL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4112","BK4139","LU0314104364.USD","LU2089984988.USD","LU1974910355.USD","LU2362540622.SGD","SG9999014013.SGD","LU2362541513.USD","LU1917777945.USD","LU0882574055.USD","LU0053666078.USD","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0823416689.USD","LU2210149790.SGD","BK4588","BK4585","LU0889565916.HKD","LU0320765992.SGD","LU2468319806.SGD","IE00BN0W2W23.USD","LU0114720955.EUR","LU2362541273.HKD","NDAQ","IE00BN0W2T93.GBP","SG9999014021.USD","LU2023250504.SGD","LU0289739699.SGD","LU2095319765.USD","LU2210150020.SGD","LU2106854487.HKD","LU0058720904.USD","REGN","SG9999014039.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU0823434740.USD","LU0823434583.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646802032","title":"Regeneron’s New First-in-Human Eczema Drug REGN20423: Early Trial Progress and Investor Takeaways","url":"https://stock-news.laohu8.com/highlight/detail?id=2646802032","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646802032?lang=en_us&edition=fundamental","pubTime":"2026-06-26 00:31","pubTimestamp":1782405089,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals, Inc. (REGN) is running a first-in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regenerons-new-first-in-human-eczema-drug-regn20423-early-trial-progress-and-investor-takeaways?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regenerons-new-first-in-human-eczema-drug-regn20423-early-trial-progress-and-investor-takeaways?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1974910355.USD","LU1917777945.USD","LU0109394709.USD","LU0053666078.USD","PRGS","LU0889565916.HKD","LU0058720904.USD","LU0823416689.USD","LU0289739699.SGD","BK4585","LU2089984988.USD","LU2362541513.USD","LU2237438978.USD","LU2065732104.USD","LU2106854487.HKD","LU0882574055.USD","BK4139","REGN","LU2362540622.SGD","LU0320765992.SGD","LU0823434583.USD","BK4588","LU0823434740.USD","LU2468319806.SGD","LU0114720955.EUR","BK4097","LU2362541273.HKD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646187741","title":"Kymera Rises on Accelerated Trial Timeline for Experimental Eczema Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2646187741","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646187741?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:49","pubTimestamp":1782388192,"startTime":"0","endTime":"0","summary":"BUZZ-Kymera rises on accelerated trial timeline for experimental eczema drug** Shares of drug developer Kymera TherapeuticsKYMR.Orise 7.8% to $107.8 premarket** Co says it has completed enrollment for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4N42X14L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","IE00BFXG1179.USD","LU1116320901.HKD","LU0823434740.USD","IE00B775SV38.USD","IE00BDRTCR15.USD","LU0868494708.USD","LU1496350171.SGD","LU1670627923.USD","LU0976567544.SGD","JPMO","LU0820562030.AUD","LU1084165304.USD","LU1548497426.USD","LU1914381329.SGD","LU0640476718.USD","LU0868494617.USD","REGN","LU2211815571.USD","LU0889565916.HKD","KYMR","LU1974910355.USD","LU1145028129.USD","LU2552382215.SGD","LU2237443465.HKD","LU2756315318.SGD","LU0320765489.SGD","LU2023250843.SGD","LU0345770993.USD","IE0034235303.USD","LU2054465674.USD","LU2237443895.HKD","JPO","LU0109394709.USD","LU0882574055.USD","LU2756315664.SGD","JPX","LU2462157665.USD","LU0211328371.USD","LU0070302665.USD","LU0859254822.USD","LU2237443382.USD","LU2362541513.USD","LU0323591593.USD","BK4139","LU1668664300.SGD","IE00B1XK9C88.USD","LU2213496289.HKD","IE00BLSP4239.USD","LU2746668461.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645248690","title":"AbbVie is buying a biotech working on an experimental eczema drug for $10.9 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2645248690","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645248690?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:50","pubTimestamp":1782129000,"startTime":"0","endTime":"0","summary":"If approved, the drug would be a new option for people with atopic dermatitis. AbbVie is buying Apogee Therapeutics, which is developing a long-acting treatment for atopic dermatitis.AbbVie is acquiring a biotech company that is developing a promising atopic dermatitis drug for $10.9 billion in cash.The acquisition would be for Apogee Therapeutics, which is working on a long-acting treatment for atopic dermatitis that's set to move into Phase 3 trials later this year. The drug works by blocking IL-13, the protein that causes eczema.If approved, the drug would compete with Dupixent, an IL-4 and IL-13 inhibitor that is used to treat numerous inflammatory conditions like atopic dermatitis and chronic obstructive pulmonary disease, or COPD. That medicine, which is sold by Regeneron Pharmaceuticals  and Sanofi , is one of the world's top-selling drugs.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU0820561909.HKD","LU0868494708.USD","IE00BFTCPJ56.SGD","LU0053671581.USD","LU1989772923.USD","LU1929549753.HKD","LU1093756168.USD","LU0234572021.USD","LU0868494617.USD","IE000MB6IJN5.SGD","BK4588","LU0289739699.SGD","LU1057294990.SGD","LU0057025933.USD","LU0823434740.USD","APGE","LU0738911758.USD","SG9999015978.USD","LU1074936037.SGD","LU1037948541.HKD","LU0861579265.USD","LU0949170772.SGD","LU0310800379.SGD","LU2129689431.USD","LU2087621335.USD","ABBV","LU0965509283.SGD","LU0942090050.USD","LU0128525929.USD","LU1934455863.HKD","LU1162221912.USD","LU2237443895.HKD","LU0122379950.USD","LU0124676726.USD","LU2237438978.USD","SG9999015945.SGD","LU1934455194.USD","LU0965509101.SGD","IE00BDGV0183.EUR","LU2362541513.USD","IE00BLSP4452.SGD","REGN","LU0211328371.USD","IE0004445239.USD","LU0965508806.USD","LU0109394709.USD","LU1267930573.SGD","LU0943347566.SGD","LU1670627923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645141021","title":"Regeneron Gets FDA, EMA Review of Cemdisiran in Generalized Myasthenia Gravis","url":"https://stock-news.laohu8.com/highlight/detail?id=2645141021","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645141021?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:33","pubTimestamp":1782127980,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals said U.S. and European regulators have accepted its applications seeking approval of its cemdisiran drug candidate in the rare and chronic autoimmune disease generalized myasthenia gravis, or gMG.Regeneron on Monday said the U.S. Food and Drug Administration and the European Medicines Agency will review cemdisiran to for adults with gMG who are anti-acetylcholine receptor antibody-positive.The Tarrytown, N.Y., biotechnology company said the FDA has granted the application priority review, which shortens the review period, and that it set a target action date in November.Regeneron, which is developing cemdisiran under a licensing agreement with Alnylam Pharmaceuticals, said it expects a decision from the European Commission in the second half of 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU2362541273.HKD","LU2023250504.SGD","LU2106854487.HKD","LU2089984988.USD","LU0823434740.USD","LU1917777945.USD","LU2468319806.SGD","LU0882574055.USD","BK4588","LU0109394709.USD","LABU","LU0889565916.HKD","LU0053666078.USD","BK4139","LU0823434583.USD","LU2237438978.USD","LU0320765992.SGD","LU1974910355.USD","LU0114720955.EUR","BK4548","REGN","LU0289739699.SGD","BK4585","LU2362540622.SGD","LU0058720904.USD","ALNY","EMA","BK4081","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029935","title":"Regeneron says FDA accepts cemdisiran gMG filing for priority review","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029935","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029935?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126059,"startTime":"0","endTime":"0","summary":"Regeneron’s FDA application for cemdisiran in anti-AChR antibody-positive generalized myasthenia gravis was accepted under Priority Review.FDA target action date set for November 2026, supported by a Priority Review Voucher.EMA also validated the filing; a European Commission decision is expected in the second half of 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL9dkh2n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","REGN","LU0109394709.USD","BK4139","IE00BKPKM429.USD","LU0289739699.SGD","IE00B64PRP62.GBP","LU2362541513.USD","NDAQ","LU1917777945.USD","LU2237438978.USD","LU0114720955.EUR","LU2468319806.SGD","LU1974910355.USD","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","LU0058720904.USD","BK4585","LU0823434740.USD","LU2106854487.HKD","IE00BN0W2V16.EUR","SG9999014039.USD","LU2210150020.SGD","LU0889565916.HKD","LU2023250504.SGD","LU2089984988.USD","IE00BN0W2T93.GBP","LU0320765992.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","BK4588","LU0314104364.USD","BK4112","IE00BN0W2W23.USD","LU0882574055.USD","LU2362540622.SGD","LU0823434583.USD","LU2210149790.SGD","LU0053666078.USD","LU0823416689.USD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645951029","title":"Regeneron Pharmaceuticals - FDA to Review Cemdisiran Nda Under Priority Review With Target Action Date November 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2645951029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645951029?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUA2BRBYY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","LU2023250504.SGD","LU1917777945.USD","LU0823434740.USD","REGN","LU0320765992.SGD","LU0889565916.HKD","LU1974910355.USD","LU0109394709.USD","LU2362540622.SGD","LU2468319806.SGD","LU2237438978.USD","BK4139","LU2362541273.HKD","LU0823434583.USD","LU0823416689.USD","LU0053666078.USD","LU2106854487.HKD","BK4585","BK4588","LU2089984988.USD","LU0289739699.SGD","LU2362541513.USD","LU0882574055.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645802995","title":"Regeneron Pharmaceuticals - European Commission Decision on Cemdisiran Expected in Second Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2645802995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645802995?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUA2BRBYY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823416689.USD","LU2362541273.HKD","LU2023250504.SGD","LU2106854487.HKD","LU2089984988.USD","LU0823434740.USD","LU1917777945.USD","LU2468319806.SGD","LU0882574055.USD","BK4588","LU0109394709.USD","LU0889565916.HKD","LU0053666078.USD","BK4139","LU0823434583.USD","LU2237438978.USD","LU0320765992.SGD","LU1974910355.USD","LU0114720955.EUR","REGN","LU0289739699.SGD","BK4585","LU2362540622.SGD","LU0058720904.USD","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regeneron.com","stockEarnings":[{"period":"1week","weight":0.055},{"period":"1month","weight":0.0852},{"period":"3month","weight":-0.1412},{"period":"6month","weight":-0.1572},{"period":"1year","weight":0.1945},{"period":"ytd","weight":-0.1524}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.514286,"avgChangeRate":0.03675},{"month":2,"riseRate":0.428571,"avgChangeRate":0.086855},{"month":3,"riseRate":0.457143,"avgChangeRate":-0.043382},{"month":4,"riseRate":0.457143,"avgChangeRate":0.014275},{"month":5,"riseRate":0.611111,"avgChangeRate":0.052257},{"month":6,"riseRate":0.444444,"avgChangeRate":0.006953},{"month":7,"riseRate":0.666667,"avgChangeRate":0.052552},{"month":8,"riseRate":0.542857,"avgChangeRate":0.022877},{"month":9,"riseRate":0.457143,"avgChangeRate":0.023281},{"month":10,"riseRate":0.4,"avgChangeRate":-0.00141},{"month":11,"riseRate":0.542857,"avgChangeRate":0.046018},{"month":12,"riseRate":0.485714,"avgChangeRate":0.043803}],"exchange":"NASDAQ","name":"Regeneron Pharmaceuticals","nameEN":"Regeneron Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Regeneron Pharmaceuticals(REGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Regeneron Pharmaceuticals,REGN,Regeneron Pharmaceuticals股票,Regeneron Pharmaceuticals股票老虎,Regeneron Pharmaceuticals股票老虎国际,Regeneron Pharmaceuticals行情,Regeneron Pharmaceuticals股票行情,Regeneron Pharmaceuticals股价,Regeneron Pharmaceuticals股市,Regeneron Pharmaceuticals股票价格,Regeneron Pharmaceuticals股票交易,Regeneron Pharmaceuticals股票购买,Regeneron Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Regeneron Pharmaceuticals(REGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}